BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23684750)

  • 1. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
    Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
    Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
    Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
    Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
    Aly HH; Shimotohno K; Hijikata M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
    Aly HH; Qi Y; Atsuzawa K; Usuda N; Takada Y; Mizokami M; Shimotohno K; Hijikata M
    Hepatology; 2009 Sep; 50(3):689-96. PubMed ID: 19489071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
    Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
    J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes.
    Ndongo-Thiam N; Berthillon P; Errazuriz E; Bordes I; De Sequeira S; Trépo C; Petit MA
    Hepatology; 2011 Aug; 54(2):406-17. PubMed ID: 21520209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone.
    Maeda N; Watanabe M; Okamoto S; Kanai T; Yamada T; Hata J; Hozumi N; Katsume A; Nuriya H; Sandhu J; Ishii H; Kohara M; Hibi T
    Liver Int; 2004 Jun; 24(3):259-67. PubMed ID: 15189278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
    Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
    Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition.
    Cyrus T; Ding T; Praticò D
    Atherosclerosis; 2010 Feb; 208(2):376-81. PubMed ID: 19735918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
    Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
    Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production.
    Nourbakhsh M; Douglas DN; Pu CH; Lewis JT; Kawahara T; Lisboa LF; Wei E; Asthana S; Quiroga AD; Law LM; Chen C; Addison WR; Nelson R; Houghton M; Lehner R; Kneteman NM
    J Hepatol; 2013 Aug; 59(2):336-43. PubMed ID: 23542347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway.
    Huang RY; Li MY; Ng CS; Wan IY; Kong AW; Du J; Long X; Underwood MJ; Mok TS; Chen GG
    J Mol Cell Biol; 2013 Dec; 5(6):380-90. PubMed ID: 24115277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.